Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Traumatic Heel Pad Injuries in Children
NCT04219657Phase 1Completed
- Sponsor
- King Edward Medical University
- Start
- Oct 2016
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mesenchymal stem cells (2 arms), sponsored by King Edward Medical University. Primary endpoint: Ranges of Movement of ankle joint at 12 weeks. Started Oct 2016; status: completed.
02
Drugs
mesenchymal stem cells
Beyond the preview
Go deeper on NCT04219657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04219657.